Why Illumina Jumped 9.8% in November
Shares of the genomic sequencing specialist Illumina (NASDAQ: ILMN) rose nearly 10% in November, according to data from S&P Global Market Intelligence. However, there wasn't any company-specific news that can justify the move. Shareholders can likely chalk up the jump to continued enthusiasm for the company's breakout year.
Image source: Getty Images.
While there wasn't any big news released during the month, the company did have a few positive announcements to make, including:
Source: Fool.com
Illumina Inc. Aktie
166,80 €
1,01 %
Positive Tendenz bei Illumina Inc. mit mehreren Buy-Einschätzungen als Sell-Einschätzungen.
Das von der Community festgelegte Kursziel von 179 € für Illumina Inc. deutet auf ein leichtes Wachstumspotenzial im Vergleich zu 166.8 € hin.
